000 01172 a2200349 4500
005 20250517235038.0
008 ####s 0 0 eng d
022 _a1792-0981
024 7 _a10.3892/etm.2018.6459
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJiang, Nan
245 0 0 _aNovel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs.
_h[electronic resource]
260 _bExperimental and therapeutic medicine
_cSep 2018
300 _a2183-2192 p.
_bdigital
500 _aPublication Type: Journal Article; Review
700 1 _aLin, Jing-Jing
700 1 _aWang, Jun
700 1 _aZhang, Bei-Ning
700 1 _aLi, Ao
700 1 _aChen, Zheng-Yang
700 1 _aGuo, Song
700 1 _aLi, Bin-Bin
700 1 _aDuan, Yu-Zhong
700 1 _aYan, Ru-Yi
700 1 _aYan, Hong-Feng
700 1 _aFu, Xiao-Yan
700 1 _aZhou, Jin-Lian
700 1 _aYang, He-Ming
700 1 _aCui, Yan
773 0 _tExperimental and therapeutic medicine
_gvol. 16
_gno. 3
_gp. 2183-2192
856 4 0 _uhttps://doi.org/10.3892/etm.2018.6459
_zAvailable from publisher's website
999 _c28807253
_d28807253